Update of the ACCORD Eye Study
- 13 January 2011
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 364 (2), 188-189
- https://doi.org/10.1056/nejmc1011499
Abstract
We wish to update our report on the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye study (July 15, 2010, issue).1 We made a mistake in the calculation of vision loss that also affected another article.2 Our intent was to define moderate vision loss as a 15-letter decrease on the visual acuity score from baseline in either eye. However, in the analyses described in the published reports,1,2 this calculation was erroneously made on the basis of the right eye only, resulting in fewer events as well as fewer people in whom a change in visual acuity could be ascertained. The published and revised numbers are presented in Table 1 ; the article is correct at NEJM.org. These changes do not materially change the conclusions of the study.This publication has 2 references indexed in Scilit:
- Effects of Medical Therapies on Retinopathy Progression in Type 2 DiabetesNew England Journal of Medicine, 2010
- Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trialThe Lancet, 2010